Cargando…

BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages

High-grade serous ovarian cancer (HGSOC), with its high recurrence rates, urges for reasonable therapeutic strategies that can prolong overall survival. A tumor microenvironment (TME) discloses prognostic and prospective information on cancer, such as the expression level of PD-1 or PD-L1. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xi, Fu, Yu, Yang, Bin, Guo, Ensong, Wu, Yifan, Huang, Jia, Zhang, Xiaoxiao, Xiao, Rourou, Li, Kezhen, Wang, Beibei, Hu, Junbo, Sun, Chaoyang, Chen, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058627/ https://www.ncbi.nlm.nih.gov/pubmed/32184777 http://dx.doi.org/10.3389/fimmu.2020.00089

Ejemplares similares

AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells
por: Lin, Cho-Hao, et al.
Publicado: (2022)

BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor
por: Zhang, Peng, et al.
Publicado: (2019)

Translational Modeling of Drug‐Induced Myelosuppression and Effect of Pretreatment Myelosuppression for AZD5153, a Selective BRD4 Inhibitor
por: Collins, TA, et al.
Publicado: (2017)

BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor: Erratum
por: Zhang, Peng, et al.
Publicado: (2022)

Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer
por: Xiao, Rourou, et al.
Publicado: (2022)

BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors
por: Fu, Yu, et al.
Publicado: (2023)

First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma
por: Hamilton, Erika P., et al.
Publicado: (2023)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021)

The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer
por: Liu, Chen, et al.
Publicado: (2022)

The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis
por: Schilter, Heidi, et al.
Publicado: (2018)

HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells
por: Lu, Hao, et al.
Publicado: (2016)

Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection
por: Yang, Bin, et al.
Publicado: (2021)

BRD4 Inhibition Attenuates Inflammatory Pain by Ameliorating NLRP3 Inflammasome-Induced Pyroptosis
por: Hua, Tong, et al.
Publicado: (2022)

M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma
por: Yang, Long, et al.
Publicado: (2023)

Brd4 Regulates the Homeostasis of CD8(+) T-Lymphocytes and Their Proliferation in Response to Antigen Stimulation
por: Peng, Zhilin, et al.
Publicado: (2021)

Fecal microbiota transplantation mitigates vaginal atrophy in ovariectomized mice
por: Huang, Jia, et al.
Publicado: (2021)

WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway
por: Guo, Ensong, et al.
Publicado: (2021)

Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis
por: Shan, Wanying, et al.
Publicado: (2016)

JQ1 as a BRD4 Inhibitor Blocks Inflammatory Pyroptosis-Related Acute Colon Injury Induced by LPS
por: Chen, Ling, et al.
Publicado: (2021)

Value and Challenges: Nucleic Acid Amplification Tests for SARS–CoV-2 in Hospitalized COVID-19 Patients
por: Meng, Yifan, et al.
Publicado: (2020)

Integrating pathology, chromosomal instability and mutations for risk stratification in early-stage endometrioid endometrial carcinoma
por: Li, Yuan, et al.
Publicado: (2020)

Novel brd4 inhibitors with a unique scaffold exhibit antitumor effects
por: Kim, Young Hun, et al.
Publicado: (2021)

Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages
por: Müller, Elisabeth, et al.
Publicado: (2017)

Slit2-Mediated Metabolic Reprogramming in Bone Marrow-Derived Macrophages Enhances Antitumor Immunity
por: Kaul, Kirti, et al.
Publicado: (2021)

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes
por: Ardighieri, Laura, et al.
Publicado: (2021)

Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction
por: Yin, Mingzhu, et al.
Publicado: (2020)

AZD-1222: Macrophage activation syndrome: case report
Publicado: (2022)

BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4
por: Ahmed, Nasiha S., et al.
Publicado: (2021)

LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization
por: Hu, Jinyang, et al.
Publicado: (2022)

Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors
por: Dacoba, Tamara G., et al.
Publicado: (2020)

Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects
por: Zhang, Jiatong, et al.
Publicado: (2022)

Epigenetic Regulation of NK Cell-Mediated Antitumor Immunity
por: Xia, Miaoran, et al.
Publicado: (2021)

Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma
por: Tu, Jihao, et al.
Publicado: (2023)

The FGFR Family Inhibitor AZD4547 Exerts an Antitumor Effect in Ovarian Cancer Cells
por: Na, Yu Ran, et al.
Publicado: (2021)

Epigenetics Regulates Antitumor Immunity in Melanoma
por: Chen, Yuhan, et al.
Publicado: (2022)

Acute Eosinophilic Pneumonia Associated With the Anti-COVID-19 Vaccine AZD1222
por: Miqdadi, Amal, et al.
Publicado: (2021)

Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis
por: Meng, Yifan, et al.
Publicado: (2020)

Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation
por: Müller, Elisabeth, et al.
Publicado: (2018)

Epigenetically altered macrophages promote development of diabetes-associated atherosclerosis
por: Huang, Dong, et al.
Publicado: (2023)

Khodakarami, H., et al., Prediction of the Levodopa Challenge Test in Parkinson’s Disease Using Data from a Wrist-Worn Sensor. Sensors 2019, 19, 5153
por: Khodakarami, Hamid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fo2clbsaeveh0pomrb885etui1